TOPIC

Biomedicine: Companies

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

3 Nov 2024 - 12:39PMvideocam

AstraZeneca’s China president under ‘ongoing investigation’: company

31 Oct 2024 - 6:03AM

Hong Kong start-ups eye Middle East capital under new accord with venture fund

29 Oct 2024 - 9:57PM

Hong Kong health tech: private-public alliance advances male HPV testing

Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.

17 Oct 2024 - 8:30AM

The Nanoswab device viewed through an optical microscope. Photo: Handout

CK Life’s Yuen banks on Big Pharma experience to boost new drug success

Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.

8 Oct 2024 - 7:13PM

WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.

4 Oct 2024 - 6:00PM

Wuxi AppTec’s upbeat business update boosts stock despite US bill

A presentation persuaded investors that risk of a potential US blacklisting is low while growth in some business areas is ‘unprecedented’.

29 Sep 2024 - 4:15PM

Shares in Chinese drug research and development group Wuxi AppTec closed up 23.9 per cent on Friday, the most since its listing in 2018. Photo: Reuters

Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

29 Sep 2024 - 7:09PMvideocam

Hong Kong’s advanced materials institute eyes bay area presence

Non-profit institute sees opportunities in licensing its technology to generate income to fund new equipment and facilities, CEO Fung says.

24 Sep 2024 - 10:51AMvideocam

Opinion | Is biotech the next battleground in US-China decoupling?

With both countries viewing technological leadership as a zero-sum game, the risk of a fragmented global innovation ecosystem is growing.

25 Sep 2024 - 4:50PMvideocam

US bill targets Chinese biotechs Wuxi AppTec, Wuxi Biologics

Shares of Wuxi AppTec and Wuxi Biologics fell after the US House passed a bill that would restrict business with Chinese biotech companies.

10 Sep 2024 - 6:31PM

A Wuxi Biologics office. Photo: Wuxi Biologics

‘China Week’ bill restricting US contracts with Chinese biotech firms among first to pass

The congressional chamber began voting Monday on a series of bills to limit Beijing’s political, economic and technological influence.

10 Sep 2024 - 10:12AM

‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs

Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.

10 Sep 2024 - 12:46AMvideocam

Foreign buyouts of Chinese drug firms spark national security fears

Some industry figures warn that sanctions could limit Chinese patients’ access to vital drugs after a series of takeovers by international firms.

6 Aug 2024 - 9:40PMvideocam

Some observers fear that selling Chinese firms to international companies could push up the cost of medicines domestically. Photo: Shutterstock

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

Research facility at the Hong Kong Science and Technology Park will conduct drug discovery in collaboration with university medical schools.

3 Aug 2024 - 8:52AM

A view of Hong Kong Science and Technology Park in Pak Shek Kok. Photo: Winson Wong

Hong Kong fund inks deal with biotech start-up as city aims for tech hub status

The Hong Kong Investment Corporation has struck a deal with a biotech firm started by Baidu founder Robin Li Yanhong, the fund’s second public move as the city seeks to boost its tech sector.

24 Jun 2024 - 4:06PM

US House panel approves bill limiting business with Chinese biotech firms

The bill would prevent federal agencies from contracting with five Chinese biotech companies – BGI Group, MGI, Complete Genomics, Wuxi AppTec, and Wuxi Biologics.

16 May 2024 - 5:19AM

Hong Kong attracts US$832 million in investment from life-science firms

The investments, which will yield 3,200 jobs, come amid government efforts to enhance Hong Kong’s position as an innovation hub in the field.

8 May 2024 - 8:49PM

The Hong Kong government has created funding incentives to support life sciences firms in every stage of their development from basic research to clinical trials, manufacturing, and marketing, official says. Photo: Shutterstock

Chinese drugs giant, Shenzhen team up to invest in city’s biomedical start-ups

Fosun Pharma will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.

14 Mar 2024 - 7:00PMvideocam

Drug development can take over a decade. AI helped make a medicine in 18 months

Evidence that AI tools can slash years off early-stage analysis will ‘revolutionise drug discovery’, researchers say.

14 Mar 2024 - 1:03AMvideocam

Time to ‘cut off’ US outbound investment in China biotech firms: House panel

Bipartisan support on show amid concern ‘every bit of value flowing’ to companies in the industry ‘will be used to strengthen the CCP and the PLA’.

8 Mar 2024 - 6:05AMvideocam

Covid-19 testing in an inflatable lab provided by Chinese biotech firm, BGI Genomics, a subsidiary of BGI Group, in Beijing in 2020. US lawmakers have raised alarm over such companies’ reach in the American market. Photo: Xinhua via AP

US lawmaker moves to ban Chinese biotech firms from contracts on military link

The bill cites Chinese entities such as Third Military Medical University and Key Laboratory of High-Altitude Medicine as examples of ‘espionage tools’ of the Communist Party.

26 Jan 2024 - 5:35PMvideocam

Chinese biotech stocks took a beating on Friday after a US lawmaker alleged some entities had links to the army. Photo: Getty Images

Local production of cells to ‘cut treatment cost for Hong Kong leukaemia patients’

Xellera Therapeutics became the first biotech firm to receive licensing to make CAR T-cells locally in laboratory.

10 Oct 2023 - 9:25PM

China’s healthcare tycoons lose US$17 billion as crackdown spreads

The combined fortune of the top 15 Chinese healthcare billionaires has fallen 17 per cent to US$84.1 billion amid a sweeping anti-corruption campaign that started about two months ago.

21 Sep 2023 - 3:19PM

Big pharma preferred over old favourite biotech firms by foreign investors

Big Chinese pharmaceutical firms with a track record of profits will be key beneficiaries of China reopening, with pre-revenue biotechnology companies falling out of favour, Citigroup says.

9 Jan 2023 - 5:46PMvideocam

Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee

Help preserve 120 years of quality journalism.

SUPPORT NOW

Biomedicine: Companies

As China bets on tech and innovation to drive its growth, it has placed its chips on several industrial sectors that are expected to play increasingly important roles in development and trade, which will bring fresh opportunities and challenges for stakeholders. SCMP’s China Future Tech is your go-to destination for the latest news, insights, and opinions on these select industries. Explore in-depth coverage of EVs, AI, semiconductors, aerospace, robotics and biomedicine sectors. Follow us to stay ahead in China's evolving competitive landscape.

last updated:

23 October, 2024